Hinge Health (NYSE:HNGE) Sets New 1-Year High – Should You Buy?

Hinge Health Inc. (NYSE:HNGE) shares reached a new 52-week high during trading on Monday . The company traded as high as $91.50 and last traded at $89.6720, with a volume of 279554 shares trading hands. The stock had previously closed at $89.33.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on HNGE shares. Citizens Jmp raised their price target on Hinge Health from $96.00 to $107.00 and gave the company a “market outperform” rating in a research report on Wednesday, August 5th. Piper Sandler reiterated an “overweight” rating on shares of Hinge Health in a report on Wednesday, June 10th. Evercore reissued an “outperform” rating and set a $105.00 price objective on shares of Hinge Health in a report on Wednesday, August 5th. Wells Fargo & Company boosted their target price on Hinge Health from $90.00 to $103.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 5th. Finally, Morgan Stanley upped their target price on Hinge Health from $72.00 to $108.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $100.57.

Hinge Health Price Performance

The firm has a market capitalization of $6.89 billion, a P/E ratio of 69.59 and a beta of 1.31. The firm’s 50 day simple moving average is $77.44 and its two-hundred day simple moving average is $55.70.

Hinge Health (NYSE:HNGE) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.31. The firm had revenue of $212.82 million for the quarter. Hinge Health had a return on equity of 65.44% and a net margin of 15.15%.The firm’s quarterly revenue was up 53.0% compared to the same quarter last year. During the same period last year, the business posted $0.59 earnings per share. As a group, equities research analysts forecast that Hinge Health Inc. will post 1.37 EPS for the current year.

Insider Activity at Hinge Health

In other Hinge Health news, President James Pursley sold 33,000 shares of the business’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $69.31, for a total value of $2,287,230.00. Following the completion of the sale, the president owned 740,897 shares in the company, valued at approximately $51,351,571.07. The trade was a 4.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Insight Holdings Group, Llc sold 181,499 shares of the stock in a transaction that occurred on Thursday, July 9th. The shares were sold at an average price of $90.20, for a total value of $16,371,209.80. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 3,715,194 shares of company stock worth $287,886,932 in the last ninety days. 18.92% of the stock is owned by company insiders.

Institutional Investors Weigh In On Hinge Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HNGE. BIT Capital GmbH boosted its position in Hinge Health by 79.3% during the 4th quarter. BIT Capital GmbH now owns 3,316,101 shares of the company’s stock valued at $154,033,000 after buying an additional 1,466,577 shares during the period. Vanguard Group Inc. raised its stake in shares of Hinge Health by 110.5% during the fourth quarter. Vanguard Group Inc. now owns 2,605,532 shares of the company’s stock valued at $121,027,000 after acquiring an additional 1,367,693 shares during the last quarter. Tiger Global Management LLC raised its stake in shares of Hinge Health by 227.1% during the fourth quarter. Tiger Global Management LLC now owns 1,805,751 shares of the company’s stock valued at $83,877,000 after acquiring an additional 1,253,743 shares during the last quarter. Millennium Management LLC boosted its holdings in shares of Hinge Health by 225.0% during the fourth quarter. Millennium Management LLC now owns 1,479,642 shares of the company’s stock worth $68,729,000 after purchasing an additional 1,024,317 shares during the period. Finally, Braidwell LP raised its position in Hinge Health by 43.3% during the 4th quarter. Braidwell LP now owns 1,304,623 shares of the company’s stock valued at $60,600,000 after purchasing an additional 394,147 shares during the last quarter.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.